MERCK ,,, Buy opportunity Uptrend
It is a good passing out from a price level and getting buying position has low amount of risk.
Entry suggested by setting SL at a good place and targeting at about 230 as the first one.
7.17USD
3.12 BUSD
23.17 BUSD
129.23 M
About Merck KGaA
Sector
CEO
Belén Garijo López
Headquarters
Darmstadt
Website
Employees (FY)
62.91 K
ISIN
DE0006599905
FIGI
BBG000P3VYP9
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
MRK // triangle patternLet's look for a close at the crossed point for the rise. Pay attention to the wedge indicator resistance in the weekly time frame.
Bioreactor markets running at 20% CAGRWas researching the bio reactor space following the recent results of Sartorius and found that they three key players are Merck, Sartorius and TMO. Definitely not cheap, but the cheapest among peers, with solid fundamentals. A trade to watch out in dips.
MRK - Merck xetra - EW analysis - 3rd of 5th waveMerck (GERMANY) - It is in 3rd of 5th wave of the impulse sequence as conservative count. The next three wave correction will be good opportunity to get in to uptrend for 5th of 3rd of 5th wave near the zone 168-165.
MRK (DAX) - EW analysis - ABC correction down MRC - It is within ABC correction after completing Impulse up cycle. Stay bearish on small bounce of B wave for C wave down for target below 130.
Give thumbs up if you really like the trade idea/analysis.
MRK. Wait for pattern. and LONGMonthly
Uptrend
Weekly
Uptrend
Daily
range with no clear TP and orientirs
Trade possibe but with tight SL and speculative.
Wait for formation
MRK (MERCK)-> Analysis of 14 Sep.
-> Good Morning Friends, here my 4H-Chart idea to MERCK. Bullish outbreak Daily-Chart -> (all further information can be found in the chart)
-> Please note: These analyses are not intended as investment recommendations! The analyses presented by me are in no way to be un
Merck KGaA Another buy opportunity is appeared. Now price is on weekly trendline that is good point to go long. As you can see Lower lows turning to Higher lows. We can add position now and hold it for long time. Divergence on stochastic gives confirmation to buy. Entry point would be now at 89.00 or after bre
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where MKGAF is featured.
Frequently Asked Questions
The current price of MKGAF is 158.36 USD — it has decreased by 1.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Merck KGaA stocks are traded under the ticker MKGAF.
Merck KGaA is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
MKGAF stock is 6.17% volatile and has beta coefficient of 0.86. Check out the list of the most volatile stocks — is Merck KGaA there?
MKGAF earnings for the last quarter are 2.19 USD per share, whereas the estimation was 2.09 USD resulting in a 4.58% surprise. The estimated earnings for the next quarter are 2.11 USD per share. See more details about Merck KGaA earnings.
Merck KGaA revenue for the last quarter amounts to 5.47 B USD despite the estimated figure of 5.51 B USD. In the next quarter revenue is expected to reach 5.79 B USD.
Yes, you can track Merck KGaA financials in yearly and quarterly reports right on TradingView.
MKGAF stock has risen by 0.96% compared to the previous week, the month change is a 9.20% fall, over the last year Merck KGaA has showed a 10.58% decrease.
MKGAF net income for the last quarter is 646.79 M USD, while the quarter before that showed 780.13 M USD of net income which accounts for −17.09% change. Track more Merck KGaA financial stats to get the full picture.
Today Merck KGaA has the market capitalization of 71.50 B, it has decreased by 1.95% over the last week.
Yes, MKGAF dividends are paid annually. The last dividend per share was 2.42 USD. As of today, Dividend Yield (TTM)% is 1.43%. Tracking Merck KGaA dividends might help you take more informed decisions.
Merck KGaA dividend yield was 1.53% in 2023, and payout ratio reached 33.87%. The year before the numbers were 1.22% and 28.76% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MKGAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck KGaA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 62.91 K employees. See our rating of the largest employees — is Merck KGaA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck KGaA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck KGaA stock shows the sell signal. See more of Merck KGaA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Merck KGaA future price: according to them, MKGAF price has a max estimate of 224.11 USD and a min estimate of 165.41 USD. Read a more detailed Merck KGaA forecast: see what analysts think of Merck KGaA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck KGaA EBITDA is 6.91 B USD, and current EBITDA margin is 27.75%. See more stats in Merck KGaA financial statements.